XEDIMPRO

Serial Number 87647112
606

Registration Progress

Application Filed
Oct 16, 2017
Under Examination
Mar 27, 2018
Approved for Publication
Jan 30, 2018
Published for Opposition
Jan 30, 2018
Registered

Trademark Image

XEDIMPRO

Basic Information

Serial Number
87647112
Filing Date
October 16, 2017
Published for Opposition
January 30, 2018
Abandonment Date
October 29, 2018
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Oct 29, 2018
Classes
005

Rights Holder

AstraZeneca AB

99
Address
Vastra Malarehamnen 9
Södertälje SE-15185
SE

Ownership History

AstraZeneca AB

Original Applicant
99
Södertälje SE

AstraZeneca AB

Owner at Publication
99
Södertälje SE

Legal Representation

Attorney
Wm. Charles Saunders

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

15 events
Date Code Type Description Documents
Oct 29, 2018 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Oct 29, 2018 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Mar 27, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 30, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 30, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 10, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 15, 2017 ALIE A ASSIGNED TO LIE Loading...
Dec 1, 2017 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Dec 1, 2017 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Dec 1, 2017 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Dec 1, 2017 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Dec 1, 2017 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 29, 2017 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 25, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 19, 2017 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005